Protocol for the diagnosis, management and treatment of pediatric patients with COVID-19 according to the recommendations of the Slovakian Pediatric Society
https://doi.org/10.21508/1027-4065-2020-65-5-93-99
Abstract
The article describes a treatment protocol for pediatric patients with COVID-19 (SARS-CoV-2 virus) in Slovakia according to the recommendations of the Slovakian Pediatric Society. The aim of the article is to demonstrate possible treatment ways of pediatric patients with confirmed and probable COVID-19. This protocol is of exploratory nature, since it may be changed due to the large amount of incoming information.
About the Authors
K. Kralinsky
Second Children’s Clinic of Slovak Medical University, Children’s Department Hospital and Polyclinic; Health Care Department of Slovak Medical University
Slovakia
Slovakia
Banska Bystrica
M. Pisarchikova
Clinic for Pediatric Anesthesiology and Intensive Medicine, Department of Medicine of the Shafarik Kosice University and Children’s University Hospital
Slovakia
Slovakia
Kosice
A. E. Dobrovanov
Getlik Clinic for Children and Adolescents, Slovak Medical University and University Hospital; St. Elizabeth University of Health and Social Sciences
Slovakia
Slovakia
Bratislava
R. Babela
Institute of Medical Disciplines, St. Elizabeth University of Health and Social sciences; National Cancer Institute
Slovakia
Slovakia
Bratislava
References
1. Cruz A., Zeichner S.L. COVID-19 in children: initial characterization of the pediatric disease. Pediatrics 2020; 145: (6): e20200834. DOI: 10.1542/peds.2020-0834
2. Suvada J., Jarcuska P. Standard Procedure for Rapid Guidance of Clinical Management of Pediatric and Adult Patients with New Coronavirus 2019 (COVID-19). Revision 1 (Ministry of Health of the Slovak Republic). https://standardnepos-tupy.sk/_files/200000238-5165751659/SDTP_korona_web.pdf (Ссылка активна на 29.06.2020.)
3. Guideline of the Chief Hygienist of the Slovak Republic in connection with the COVID-19 disease caused by the coronavirus SARS-CoV-2 (sixth update). http://www.uvzsr.sk/index.php?option=com_content&view=article&id=4156:usmernenie-hlavneho-hygienika-slovenskej-republiky-v-su-vislosti-s-ochorenim-covid-19-sposobenym-koronaviru-som-sars-cov-2-iesta-aktualizacia&catid=250:koronavi-rus-2019-ncov&Itemid=153 (Ссылка активна на 29.06.2020.)
4. Dan S, Hui L, Xiao X.L., Han X., Jie R., Fu R.Z., Zhi S.L. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr 2020; 16: 251-259. DOI: 10.1007/s12519-020-00354-4
5. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z. et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145: (6): e20200702. DOI: 10.1542/peds.2020-0702
6. Kunling S., Yonghong Y., Tianyou W., Dongchi Z, Yi J., Run-ming J. et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr 2020; 16: 223-231. DOI: 10.1007/s12519-020-00343-7
7. Tang G. Perioperative management of suspected/confirmed cases COVID-19. Tutorial 421. Anaesthesia. www.wfsahq.org/resources/anaesthesia-tutorial-of-the-week (Ссылка активна на 20.04.2020.)
8. Specific Antiviral Therapy in the Clinical Management of Acute Respiratory Infection with SARS-CoV-2 (COVID-19). Approved by: Dr Vida Hamilton, HSE National Clinical Advisor and Group Lead, Acute Hospitals. https://www.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antivi-ral-therapy-in-the-clinical-management-of-acute-respirato-ry-infection-with-sars-cov-2-covid-19.pdf (Ссылка активна на 29.06.2020.)
9. State institute for drug control of Slovakia. Ex tempore medicinal products and preparations potentially used in the treatment of children with diagnosis Covid-19. https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/lieky-a-pripravky-ex-tempore-potencialne-vyuzitelne-pri-liecbe-deti-s-diagnozou-covid-19?page_id=5323 (Ссылка активна на 29.06.2020.)
10. Summaries of evidence from selected experimental therapeutics, as of October 2018. https://www.who.int/ebola/drc-2018/summaries-of-evidence-experimental-therapeutics.pdf?ua=1 (Ссылка активна на 29.06.2020.)
11. World Health Organization 2019. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: Interim Guidance. https://apps.who.int/iris/bitstream/han-dle/10665/178529/WHO_MERS_Clinical_15.1_eng.pdf?se-quence=1 (Ссылка активна на 29.06.2020.)
12. Gruppo Italiano per la Valutazione degli Interventi in Tera-pia Intensiva. http://giviti.marionegri.it/ (Ссылка активна на 29.06.2020.)
13. Sinha I., Hey A. Guidance for the clinical management of children admitted to hospital with suspected COVID-19. British Pediatric Respiratory Society. https://www.rcpch.ac.uk/sites/default/files/2020-03/bprs_management_of_children_admitted_to_hospital_with_covid19_-_20200319.pdf (Ссылка активна на 29.06.2020.)
14. Summary of Product Characteristic (SPC), state institute for drug control (Slovakia), инструкции по применению отдельных лекарств, институт по контролю лекарств (Словакия). https://www.sukl.sk (Ссылка активна на 29.6.2020.)
15. NIH clinical trial of remdesivir to treat COVID-19 begins. Study enrolling hospitalized adults with COVID-19 in Nebraska. https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins (Ссылка активна на 29.06.2020.)
16. Tang G. Perioperative management of suspected/confirmed cases COVID-19. Tutorial 421. Anaesthesia. www.wfsahq.org/resources/anaesthesia-tutorial-of-the-week (Ссылка активна на 20.04.2020.)
17. Spalek P. Basic principles of corticosteroid treatment in autoimmune neuromuscular disorders. Neurol Prax 2011; 12(6): 368-372.
18. European Medicines Agency. 2018. Guideline on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIg). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investiga-tion-human-normal-immunoglobulin-intravenous-adminis-tration-ivig-rev-3_en.pdf (Ссылка активна на 29.06.2020.)
19. Dobrovanov O., Kralinsky K., Kovalchuk VP. Etiologicke agens infekcii mocovych ciest a mikrobialna rezistencia: retrospek-tivna sthdia. Lek Obzor 2019; 68(7): 186-190.
20. Kralinsky K., KmecovaL., Dobrovanov O. Nova era antimikro-bialnej terapie. Abstrakty prednasok. 50. celoslovenska pedi-atricka konferencia s medzinarodnou hcast’ou Galandove dni. Pediatria (Slovakia.) 2018; S3/13: 12-13.
21. Dobrovanov O., Kralinsky K., Krcmery V. Zaciatok sezony respiracnych infekcii a inicialna antibioticka terapia. Pediatria (Bratisl.) 2018; 13(5): 245-250.
22. Kolosova N.G., Geppe N.A., Dronov I.A. Approaches to the treatment of bacterial infections of the respiratory tract based on current data of the microbiome. Rossiyskiy Vest-nik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2019; 64(1): 125-129. (In Russ..) DOI: 10.21508/1027-4065-2019-64-1-125-129
23. Hyrdel R. Peptic ulcer pharmacotherapy. Via Pract 2005; 2(6): 321-325.
Review
For citations:
Kralinsky K., Pisarchikova M., Dobrovanov A.E., Babela R. Protocol for the diagnosis, management and treatment of pediatric patients with COVID-19 according to the recommendations of the Slovakian Pediatric Society. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(5):93-99. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-5-93-99
Views:
4662
Email this article 